No relief in sight for Karvy lenders
The Securities and Exchange Board of India (Sebi) is unlikely to provide any relief to the four embattled financial institutions that had lent to Karvy Stock Broking, which, in turn, had placed client securities as collateral. Read here
Clinical trials for faster availability of new drugs
Concerned about the rise of antibiotic resistance and the time it takes for drugs developed abroad to reach Indians, the government is considering holding its own clinical trials. The trials, to be held by the Indian Council of Medical Research (ICMR), could be the beginning

)